Actively Recruiting
Evaluating Transforaminal Epidural Steroid Injection Effects on Neuropathic Pain Using the Neuropathic Pain Scale in Patients with Lumbosacral Radiculopathy
Led by Marmara University · Updated on 2026-09-02
40
Participants Needed
1
Research Sites
2 weeks
Total Duration
AI-Summary
What This Trial Is About
Lumbosacral radiculopathy often causes chronic low back and leg pain with neuropathic symptoms due to nerve root compression, which can significantly reduce quality of life and daily function. This trial evaluates how transforaminal epidural steroid injection TFESI, a minimally invasive treatment, affects neuropathic pain severity in patients with this condition. The study measures pain changes using the Neuropathic Pain Scale NPS and compares clinical outcomes before and after treatment. Participants diagnosed with lumbosacral radiculopathy and experiencing neuropathic pain will receive TFESI under fluoroscopic guidance. The study focuses on a single treatment group where neuropathic pain severity and other clinical parameters like pain intensity and functional disability are assessed. Evaluations occur at baseline, then at 3 weeks and 3 months post-injection. During the study, participants will complete questionnaires and undergo clinical assessments at these timepoints to track changes in neuropathic pain using NPS, pain intensity with the Numeric Rating Scale, symptom evaluation with DN4, and disability with the Oswestry Disability Index. Researchers will also examine the relationship between imaging findings and clinical outcomes. The overall participation lasts about 3 months following the procedure, with follow-up visits to monitor effects and safety.
CONDITIONS
Brief Title
TFESI and Neuropathic Pain in Lumbosacral Radiculopathy
Research Team
E
Ece Reşit, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here